Breaking News Headlines Today

News about Moderna

Stay current with all the latest and breaking news about Moderna, compare headlines and perspectives between news sources on stories happening today. In total, 29 stories have been published about Moderna which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Moderna News

Moderna · Germany

Is Super Micro Computer Stock Headed for $15 or $70 After Giant Post-Earnings Plunge?

Following a sharp post-earnings tumble, can Super Micro Computer still climb to $70, or will it crash further?See the Story

Moderna · United States

Why Is Novo Nordisk Stock Crashing, and Is It a Buying Opportunity? @themotleyfool #stocks $NVO

Coverage: 2 sources

Novo Nordisk (NYSE: NVO) is struggling with competition from both compounders and larger rivals. *Stock prices used were the afternoon prices of July 29, 2025. The video was published on July 31, 2025.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Mo…Moderna · United States See the Story

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.

67% Left coverage: 3 sources

Moderna also lost less than Wall Street analysts were expecting for the second quarter and posted revenue that topped estimates.Wall Street · United Kingdom See the Story

Pharmalittle: We're reading about Prasad's downfall at FDA, Moderna job cuts, and much more

100% Center coverage: 1 sources

Novartis Pharmaceuticals is suing Oregon over a drug-pricing law it says forces drugmakers into providing sprawling discountsModerna · Oregon Read Article

Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow

60% Center coverage: 20 sources

Moderna · United States See the Story

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

100% Left coverage: 3 sources

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the COVID-19 vaccine Spikevax®, targeting the SARS-CoV-2 variant LP.8.1, for active…European Union · Cambridge See the Story

Wealthfront Advisers LLC Purchases 18,268 Shares of Moderna, Inc. (NASDAQ:MRNA)

Wealthfront Advisers LLC lifted its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 143.3% in the first quarter, Holdings Channel.com reports. The institutional investor owned 31,018 shares of the company’s stock after buying an additional 18,268 shares during the period. Wealthfront Advisers LLC’s holdings in Moderna were worth $879,000 at the end of the […]Moderna See the Story

Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Older

59% Center coverage: 44 sources

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.Moderna · United States See the Story

News about Moderna

News about Moderna

Covered Most By

Local News Publishers

Top Moderna News

Is Super Micro Computer Stock Headed for $15 or $70 After Giant Post-Earnings Plunge?

Merck & Co to cut 6000 jobs, Moderna to cut around 500

The Trade Desk (NASDAQ:TTD) Shares Acquired by Arkadios Wealth Advisors

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Why Is Novo Nordisk Stock Crashing, and Is It a Buying Opportunity? @themotleyfool #stocks $NVO

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.

Pharmalittle: We're reading about Prasad's downfall at FDA, Moderna job cuts, and much more

Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

Wealthfront Advisers LLC Purchases 18,268 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Older

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Moderna

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Why Is Novo Nordisk Stock Crashing, and Is It a Buying Opportunity? @themotleyfool #stocks $NVO

Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.

Pharmalittle: We're reading about Prasad's downfall at FDA, Moderna job cuts, and much more

Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

Wealthfront Advisers LLC Purchases 18,268 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Older